Showing results (81-90 of 90) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Molecular Plant|April 2, 2025
The dual-targeted transcription factor BAI1 orchestrates nuclear and plastid gene transcription in land plantsJing Qin, Yelin Shan, Hao Liu, et al.Journal of the American College of Cardiology|July 3, 2024
Coronary Artery Bypass Graft Failure in Women: Incidence and Clinical ImplicationsSigrid Sandner, Björn Redfors, Kevin R An, et al.Nature|April 9, 2025
An integrated large-scale photonic accelerator with ultralow latencyShiyue Hua, Erwan Divita, Shanshan Yu, et al.Lancet (London, England)|March 21, 2026
Angiography-derived fractional flow reserve versus coronary angiography to guide coronary artery bypass grafting in patients undergoing surgical valve procedures with concomitant coronary artery disease in China (FAVOR IV-QVAS): a multicentre, triple-blind, randomised trialYunpeng Zhu, Zhaoyun Cheng, Yuan Zhao, et al.Journal of the American College of Cardiology|July 5, 2023
P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary EventsFelice Gragnano, Davide Cao, Leah Pirondini, et al.The Annals of Thoracic Surgery|November 15, 2024
Sequential Grafting of the Left Internal Thoracic Artery to the Left Anterior Descending Artery and Graft FailureJordan Leith, Kevin R An, Lamia Harik, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|June 3, 2024
Association between overweight and obesity with coronary artery bypass graft failure: an individual patient data analysis of clinical trialsKevin R An, Sigrid Sandner, Björn Redfors, et al.BMJ (Clinical Research Ed.)|June 17, 2021
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trialsMarco Valgimigli, Felice Gragnano, Mattia Branca, et al.Journal of the American College of Cardiology|February 8, 2023
P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary InterventionsFelice Gragnano, Roxana Mehran, Mattia Branca, et al.JAMA Cardiology|March 20, 2024
Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-AnalysisMarco Valgimigli, Felice Gragnano, Mattia Branca, et al.Pageof 9